Fig. 1
From: Myostatin as a plausible biomarker for early stage of sarcopenic obesity
Proportion of participants classified into the healthy, sarcopenia-only, obesity-only, and sarcopenic obesity groups. Data are presented as the proportion of participants in each group according to age bracket. The chi-square test was used to compare proportions among the age groups. Age 30–39: n = 47, age 40–49: n = 235, age 50–59: n = 150.
